BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 17524840)

  • 21. Management of ESRD in patients with autosomal dominant polycystic kidney disease.
    Alam A; Perrone RD
    Adv Chronic Kidney Dis; 2010 Mar; 17(2):164-72. PubMed ID: 20219619
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Influence of ACE (I/D) and G460W polymorphism of alpha-adducin in autosomal dominant polycystic kidney disease.
    Persu A; El-Khattabi O; Messiaen T; Pirson Y; Chauveau D; Devuyst O
    Nephrol Dial Transplant; 2003 Oct; 18(10):2032-8. PubMed ID: 13679477
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bilateral laparoscopic nephrectomy for significantly enlarged polycystic kidneys: a technique to optimize outcome in the largest of specimens.
    Desai PJ; Castle EP; Daley SM; Swanson SK; Ferrigni RG; Humphreys MR; Andrews PE
    BJU Int; 2008 Apr; 101(8):1019-23. PubMed ID: 18190626
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Place of nephrectomy in patients with autosomal dominant polycystic kidney disease waiting for renal transplantation].
    Cohen D; Timsit MO; Chrétien Y; Thiounn N; Vassiliu V; Mamzer MF; Legendre C; Méjean A
    Prog Urol; 2008 Nov; 18(10):642-9. PubMed ID: 18971106
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Outcome of kidney transplantation in patients with polycystic kidney disease: a single center study.
    Roozbeh J; Razmkon AR; Jalaeian H; Raiss-Jalali GA; Behzadi S; Sagheb MM; Salahi H; Bahador A; Nikeghbalian S; Davari HR; Salehipour M; Malek-Hosseini SA
    Saudi J Kidney Dis Transpl; 2008 Jan; 19(1):72-5. PubMed ID: 18087127
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Simultaneous renal transplantation and native nephrectomy in patients with autosomal-dominant polycystic kidney disease.
    Nunes P; Mota A; Alves R; Figueiredo A; Parada B; Macário F; Rolo F
    Transplant Proc; 2007 Oct; 39(8):2483-5. PubMed ID: 17954154
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of colonic diverticular disease in autosomal dominant polycystic kidney disease without end-stage renal disease.
    Sharp CK; Zeligman BE; Johnson AM; Duley I; Gabow PA
    Am J Kidney Dis; 1999 Nov; 34(5):863-8. PubMed ID: 10561142
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Risk factors for urinary tract infections during the first year after kidney transplantation.
    Sorto R; Irizar SS; Delgadillo G; Alberú J; Correa-Rotter R; Morales-Buenrostro LE
    Transplant Proc; 2010; 42(1):280-1. PubMed ID: 20172330
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Survival after end-stage renal disease in autosomal dominant polycystic kidney disease: contribution of extrarenal complications to mortality.
    Perrone RD; Ruthazer R; Terrin NC
    Am J Kidney Dis; 2001 Oct; 38(4):777-84. PubMed ID: 11576881
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Management of end-stage autosomal dominant polycystic kidney disease with hemodialysis and transplantation.
    Mendelssohn DC; Harding ME; Cardella CJ; Cook GT; Uldall PR
    Clin Nephrol; 1988 Dec; 30(6):315-9. PubMed ID: 3072137
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Epidermal growth factor receptor polymorphism and autosomal dominant polycystic kidney disease.
    Magistroni R; Manfredini P; Furci L; Ligabue G; Martino C; Leonelli M; Scapoli C; Albertazzi A
    J Nephrol; 2003; 16(1):110-5. PubMed ID: 12653106
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Epidemiologic data, clinical and prognostic features of autosomal dominant polycystic kidney disease in a French region].
    Simon P; Le Goff JY; Ang KS; Charasse C; Le Cacheux P; Cam G
    Nephrologie; 1996; 17(2):123-30. PubMed ID: 8838759
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The relation of hypertension, renal function and cardiovascular events in autosomal dominant polycystic kidney disease].
    Idrizi A; Barbullushi M; Strakosha A; Kodra S; Thereska N; Zaimi E; Gjyzari A; Petrela E
    G Ital Nefrol; 2007; 24(6):595-9. PubMed ID: 18278763
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Progressive loss of renal function is an age-dependent heritable trait in type 1 autosomal dominant polycystic kidney disease.
    Paterson AD; Magistroni R; He N; Wang K; Johnson A; Fain PR; Dicks E; Parfrey P; St George-Hyslop P; Pei Y
    J Am Soc Nephrol; 2005 Mar; 16(3):755-62. PubMed ID: 15677307
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Urinary tract infections in renal allograft recipients from living related donors.
    Sqalli TH; Laboudi A; Arrayhani M; Benamar L; Amar Y; Ouzeddoun N; Bayahia R; Rhou H
    Saudi J Kidney Dis Transpl; 2008 Jul; 19(4):551-3. PubMed ID: 18580011
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Abdominal wall hernia in autosomal dominant polycystic kidney disease.
    Morris-Stiff G; Coles G; Moore R; Jurewicz A; Lord R
    Br J Surg; 1997 May; 84(5):615-7. PubMed ID: 9171744
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Socioeconomic status and the incidence of ESRD.
    Ward MM
    Am J Kidney Dis; 2008 Apr; 51(4):563-72. PubMed ID: 18371532
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Autosomal dominant polycystic kidney disease (ADPKD). in Morocco. Multicenter study about 308 families].
    Bourquia A;
    Nephrologie; 2002; 23(2):93-6. PubMed ID: 12012754
    [TBL] [Abstract][Full Text] [Related]  

  • 39. End stage polycystic kidney disease: indications and timing of native nephrectomy relative to kidney transplantation.
    Fuller TF; Brennan TV; Feng S; Kang SM; Stock PG; Freise CE
    J Urol; 2005 Dec; 174(6):2284-8. PubMed ID: 16280813
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A promoter polymorphism of the alpha 8 integrin gene and the progression of autosomal-dominant polycystic kidney disease.
    Zeltner R; Hilgers KF; Schmieder RE; Porst M; Schulze BD; Hartner A
    Nephron Clin Pract; 2008; 108(3):c169-75. PubMed ID: 18277079
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.